Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Notes Payables (2023 - 2024)

Historic Notes Payables for Cresco Labs (CRLBF) over the last 2 years, with Q4 2024 value amounting to $11.9 million.

  • Cresco Labs' Notes Payables rose 99.01% to $11.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.9 million, marking a year-over-year increase of 99.01%. This contributed to the annual value of $11.9 million for FY2024, which is 99.01% up from last year.
  • According to the latest figures from Q4 2024, Cresco Labs' Notes Payables is $11.9 million, which was up 99.01% from $11.8 million recorded in Q4 2023.
  • Cresco Labs' Notes Payables' 5-year high stood at $11.9 million during Q4 2024, with a 5-year trough of $11.8 million in Q4 2023.